Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2017 Jun 1;15(12):1957–1964.e7. doi: 10.1016/j.cgh.2017.04.046

Table 3.

Hazard Ratios (95%CI) for all-cause, cardiovascular and cancer mortality by chronic hepatitis C status in the U.S. adult population (NHANES III 1988–1994 and NHANES 1999–2012) (follow-up to December 31, 2011)

Unweighted N No CHC 35,671 CHC 527
All-Cause Mortality

Deaths, un-weighted n 5,873 115
Hazard Ratio (95%CI)
 Unadjusted 1
[Reference]
3.47 (2.56–4.70)
 Model 1a 1
[Reference]
2.93 (2.15–3.98)
 Model 2b 1
[Reference]
2.45 (1.81–3.31)
 Model 3c 1
[Reference]
2.44 (1.80–3.30)

Cardiovascular and cerebrovascular disease mortality

Deaths, un-weighted n 1,782 18
Hazard Ratio (95%CI)
 Unadjusted 1
[Reference]
2.55 (1.38–4.71)
 Model 1a 1
[Reference]
2.18 (1.18–4.03)
 Model 2b 1
[Reference]
1.87 (1.03–3.42)
 Model 3 c 1
[Reference]
1.85 (1.03–3.33)

All Cancer mortality

Deaths, un-weighted n 1,346 21
Hazard Ratio (95%CI)
 Unadjusted 1
[Reference]
1.75 (0.90–3.40)
 Model 1a 1
[Reference]
1.46 (0.75–2.85)
 Model 2b 1
[Reference]
1.16 (0.60–2.25)
 Model 3c 1
[Reference]
1.16 (0.60–2.24)
a

Model 1: Adjusted for age, age squared, sex, race/ethnicity, education

b

Model 2: Further adjusted for alcohol consumption (never, low, moderate consumption) and smoking (never, former, current)

c

Model 3: Further adjusted for diabetes (yes, no), hypertension (yes, no), albuminuria (yes, no), BMI (WHO categories)